Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2016-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,428,376
Percent of class
12.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-000647
Form type
SC 13G
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Feb 10, 2016
Reporting period
Jan 29, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub